For the past ten years, we’ve been conducting a quarterly tracking study of 12,000 people with diabetes in the United States. A lot has changed in the diabetes treatment landscape over that time!
We took a look back at the 10-year trends in drug and device penetration in the dQ&A Community.
Our longitudinal database contains over a hundred data points on each respondent per quarter. In addition to tracking which medicines and devices people use, we also have ten years of satisfaction and NPS metrics, and we know when and why people switched therapies and how their health outcomes have changed over time. These data enable us to conduct in-depth retrospective analyses, put new results into context, and hit the ground running on new projects. No learning curve or time-consuming and expensive search for target segments required.